Satipharm initiates clinical research into the use of CBD for relief from menopause symptoms

Health and wellness company Satipharm Ltd. (“Satipharm” or the “Company”) has initiated clinical research into the use of CBD for relief from menopause symptoms. Following the successful completion of its Phase II clinical trial demonstrating that Satipharm CBD capsules reduced seizures in children with treatment-resistant epilepsy by an average 73%, the company is now turning its attention to perimenopause and menopause.

Leave a Reply